Cited by 168Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.

Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies

Dickson, D.W·1997·Neurobiology of Aging

DOI 10.1016/s0197-4580(97)00065-1

Open this paper in CoChat — free account

Abstract

Alzheimer's disease (AD) is the most common cause of primary progressive dementia. It is defined by its pathological features, because the clinical syndrome of dementia lacks specificity. Although the brain in AD has many structural alterations, the two cardinal pathological features and sine qua non of AD are senile plaques and neurofibrillary degeneration. The latter takes the form of neurofibrillary tangles composed of paired helical filaments, as well as degenerating neurites within the neuropil ("neuropil threads") and within a diagnostically significant subset of SP, referred to as "neuritic plaques." All SP contain amyloid, but not all have pair helical filament-type neurites. The presence of even a small number of plaques with paired helical filament-type neurites in the neocortex is associated with cognitive impairment, and this lesion may be the most specific histopathological feature of AD. Although these observations suggest that the major difference between SP in aging and AD relate to differences in neuritic degeneration, more recent studies have also indicated that amyloid deposits are biochemically heterogenous and that amyloid deposits in aging may be different from those in AD. As more specific markers become available for recognizing AD-specific structural lesions, refined neuropathological diagnostic criteria will evolve. In the meantime, a practical neuropathological approach to the diagnosis of AD requires both widespread neocortical SP and an advanced stage of neurofibrillary degeneration. Using these criteria, it is very unlikely that AD will be diagnosed in an individual who was not demented in life. The rationale for adopting this conservative approach is that our knowledge is incomplete with respect to fundamental differences between the lesions in aging and AD.

Integrity signals

Registry

Crossref · 10.1016/s0197-4580(97)00065-1

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citation
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans
Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., & Crowther, R. A. (1996) · Nature · doi:10.1038/383550a0 · Cited by 1,036

Show all 44 references

Research works printed but not linked: 2

Dickson, D. W. Aging in the central nervous system. In: Markesbery, W., ed. Neuropathology of Dementing Disorders, Edward Arnold Publishers, London, 1997 (in press).
Dickson, 1988, Alzheimer’s disease, Am. J. Pathol., 132, 86

Sorted by citations

The neuropathological diagnosis of Alzheimer's disease
DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329
“The dense core can display radiating Aβ fibrils, and it is in these peripheral zones of the plaque where dystrophic neurites and activated microglia are concentrated, that lends credence to the hypothesis that Aβ drives neuronal degeneration and cognitive decline in AD [18, 39].”
BackgroundSelf-citation
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
“Sub-sequent studies have established that the densities of NPs correlate with antemortem cognitive impairment better than the densities of diffuse A A Ps (45, 98, 106, 154, 189, 261).”
Background
Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease
Kilgore, M., Miller, C. A., Fass, D. M., Hennig, K. M., Haggarty, S. J., Sweatt, J. D., & Rumbaugh, G. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.197 · Cited by 727
Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's Disease
Agdeppa, E. D., Kepe, V., Liu, J., Flores-Torres, S., Satyamurthy, N., Petrič, A., Cole, G. M., Small, G. W., Huang, S., & Barrio, J. R. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-24-j0004.2001 · Cited by 421
Emerging role of the cannabinoid receptor CB 2 in immune regulation: therapeutic prospects for neuroinflammation
Cabral, G. A., & Griffin-Thomas, L. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409000957 · Cited by 408
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
Fodero‐Tavoletti, M. T., Okamura, N., Furumoto, S., Mulligan, R. S., Connor, A. R., McLean, C., Cao, D., Rigopoulos, A., Cartwright, G. A., O'Keefe, G. J., et al. (2011) · Brain · doi:10.1093/brain/awr038 · Cited by 340
Inhibition of NF-κB potentiates amyloid β-mediated neuronal apoptosis
Kaltschmidt, B., Uherek, M., Wellmann, H., Volk, B., & Kaltschmidt, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9409 · Cited by 281
Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer’s Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression
Tolar, M., Hey, J., Power, A., & Abushakra, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126355 · Cited by 253
Quinoline and Benzimidazole Derivatives: Candidate Probes forIn VivoImaging of Tau Pathology in Alzheimer's Disease
Okamura, N., Suemoto, T., Furumoto, S., Suzuki, M., Shimadzu, H., Akatsu, H., Yamamoto, T., Fujiwara, H., Nemoto, M., Maruyama, M., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1738-05.2005 · Cited by 212
Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease
Haroutunian, V., Purohit, D. P., Perl, D. P., Marin, D., Khan, K., Lantz, M., Davis, K. L., & Mohs, R. C. (1999) · Archives of Neurology · doi:10.1001/archneur.56.6.713 · Cited by 201
Regional protein expression in human Alzheimer’s brain correlates with disease severity
Xu, J., Patassini, S., Rustogi, N., Riba‐Garcia, I., Hale, B. D., Phillips, A. M., Waldvogel, H. J., Haines, R., Bradbury, P., Stevens, A., et al. (2019) · Communications Biology · doi:10.1038/s42003-018-0254-9 · Cited by 182
Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease
Beauquis, J., Pavía, P., Pomilio, C., Vinuesa, A., Podlutskaya, N., Galvan, V., & Saravia, F. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.09.009 · Cited by 148
Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
Han, M. C., Nagele, E. P., DeMarshall, C. A., Acharya, N. K., & Nagele, R. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032383 · Cited by 179
Precortical Phase of Alzheimer's Disease ( AD )‐Related Tau Cytoskeletal Pathology
Stratmann, K., Heinsen, H., Korf, H., Turco, D. D., Ghebremedhin, E., Seidel, K., Bouzrou, M., Grinberg, L. T., Böhl, J., Wharton, S. B., et al. (2015) · Brain Pathology · doi:10.1111/bpa.12289 · Cited by 175
Glutamate–glutamine cycling in Alzheimer's disease
WALTON, H., & DODD, P. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2006.10.007 · Cited by 174
Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels
Zatti, G., Burgo, A., Giacomello, M., Barbiero, L., Ghidoni, R., Sinigaglia, G., Florean, C., Bagnoli, S., Binetti, G. G., Sorbi, S., et al. (2006) · Cell Calcium · doi:10.1016/j.ceca.2006.03.002 · Cited by 154
Fluorescence resonance energy transfer determinations using multiphoton fluorescence lifetime imaging microscopy to characterize amyloid-beta plaques
Bacskai, B. J., Skoch, J. M., Hickey, G. A., Allen, R., & Hyman, B. T. (2003) · Journal of Biomedical Optics · doi:10.1117/1.1584442 · Cited by 150
Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways
Žilka, N., Kazmerova, Z., Jadhav, S., Neradil, P., Maďari, A., Obetkova, D., Bugos, O., & Novák, M. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-47 · Cited by 153
Fibrillar β-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer’s disease
Matsuoka, Y., Picciano, M., LaFrancois, J. J., & Duff, K. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00115-4 · Cited by 149
Diagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
Nagele, E. P., Han, M. C., DeMarshall, C. A., Belinka, B. A., & Nagele, R. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023112 · Cited by 147
Diabetes and Hypercholesterolemia Increase Blood-Brain Barrier Permeability and Brain Amyloid Deposition: Beneficial Effects of the LpPLA2 Inhibitor Darapladib
Acharya, N. K., Levin, E. C., Clifford, P. M., Han, M., Tourtellotte, R., Chamberlain, D., Pollaro, M., Coretti, N. J., Kosciuk, M. C., Nagele, E. P., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122254 · Cited by 121
Enhanced Insight into the Autoimmune Component of Glaucoma: IgG Autoantibody Accumulation and Pro-Inflammatory Conditions in Human Glaucomatous Retina
Gramlich, O. W., Gehrke-Beck, S., Hohenstein-Blaul, N. V. T. U., Boehm, N., Ziegler, A., Vetter, J. M., Pfeiffer, N., & Grus, F. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057557 · Cited by 132
Aβ peptides can enter the brain through a defective blood–brain barrier and bind selectively to neurons
Clifford, P. M., Zarrabi, S., Siu, G., Kinsler, K., Kosciuk, M. C., Venkataraman, V., D’Andrea, M. R., Dinsmore, S. T., & Nagele, R. G. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.070 · Cited by 136
Is synaptic loss a unique hallmark of Alzheimer’s disease?
Scheff, S. W., Neltner, J. H., & Nelson, P. T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.028 · Cited by 118
Synthesis of new donepezil analogues and investigation of their effects on cholinesterase enzymes
Sağlık, B. N., Ilgın, S., & Özkay, Y. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.10.042 · Cited by 117
Contribution of vascular pathology to the clinical expression of dementia
Altschul, D., Dickson, D. W., Lipton, R. B., Katz, M. J., Derby, C. A., Lee, S. H., Wang, C., & Verghese, J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.011 · Cited by 117
Self-citation
Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases
Wang, Y., Lv, M.-N., & Zhao, W. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102035 · Cited by 122
Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease
Thomas, P., Hecker, J. R., Faunt, J., & Fenech, M. F. (2007) · Mutagenesis · doi:10.1093/mutage/gem029 · Cited by 114
2-dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease
Agdeppa, E. D. (2003) · Molecular Imaging and Biology · doi:10.1016/j.mibio.2003.09.010 · Cited by 113
SPION-Enhanced Magnetic Resonance Imaging of Alzheimer's Disease Plaques in AβPP/PS-1 Transgenic Mouse Brain
Sillerud, L. O., Solberg, N. O., Chamberlain, R., Orlando, R. A., Heidrich, J. E., Brown, D. C., Brady, C. I., Jagt, T. A. V., Garwood, M., & Jagt, D. L. V. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121171 · Cited by 106
Pathological Substrates of Cognitive Decline in Alzheimer’s Disease
Giannakopoulos, P., Kövari, E., Gold, G., von Gunten, A., Hof, P. R., & Bouras, C. (2009) · Frontiers of Neurology and Neuroscience · doi:10.1159/000197881 · Cited by 101
A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain
Ercan-Herbst, E., Ehrig, J., Schöndorf, D. C., Behrendt, A., Klaus, B., Gomez Ramos, B., Prat Oriol, N., Weber, C., & Ehrnhoefer, D. E. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0823-2 · Cited by 101
Origin of metastable oligomers and their effects on amyloid fibril self-assembly
Hasecke, F., Miti, T., Perez, C., Barton, J., Schölzel, D., Gremer, L., Grüning, C. S. R., Matthews, G., Meisl, G., Knowles, T. P. J., et al. (2018) · Chemical Science · doi:10.1039/c8sc01479e · Cited by 103
Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience
Giannakopoulos, P., Gold, G., Kövari, E., von Gunten, A., Imhof, A., Bouras, C., & Hof, P. R. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0144-y · Cited by 96
The Challenges of Tau Imaging
Villemagne, V. L., Furumoto, S., Fodero‐Tavoletti, M. T., Harada, R., Mulligan, R. S., Kudo, Y., Masters, C. L., Yanai, K., Cc, R., & Okamura, N. (2012) · Future Neurology · doi:10.2217/fnl.12.34 · Cited by 101
In vivo tau imaging: Obstacles and progress
Villemagne, V. L., & Okamura, N. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.013 · Cited by 100
Natural history of Alzheimer’s disease
Honig, L. S., & Mayeux, R. P. (2001) · Aging Clinical and Experimental Research · doi:10.1007/bf03351476 · Cited by 98
Oxidative Damage, Protein Synthesis, and Protein Degradation in Alzheimers Disease
Ding, Q., Dimayuga, E. R., & Keller, J. N. (2007) · Current Alzheimer Research · doi:10.2174/156720507779939788 · Cited by 95
Meta-Analysis of Parkinson’s Disease and Alzheimer’s Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes
Wang, Q., Li, W.-X., Dai, S.-X., Guo, Y.-C., Han, F.-F., Zheng, J.-J., Li, G.-H., & Huang, J.-F. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161032 · Cited by 88
The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits
Ye, X., Tai, W., & Zhang, D. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.004 · Cited by 90
Test-retest reproducibility for the tau PET imaging agent flortaucipir F 18.
Devous, M. D., Joshi, A. D., Navitsky, M., Southekal, S., Pontecorvo, M. J., Shen, H., Lu, M., Shankle, W. R., Seibyl, J. P., Marek, K., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.200691 · Cited by 79
The BRICHOS Domain, Amyloid Fibril Formation, and Their Relationship
Knight, S. D., Presto, J., Linse, S. S., & Johansson, J. (2013) · Biochemistry · doi:10.1021/bi400908x · Cited by 77
CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease
Koppel, J. L., Vingtdeux, V., Marambaud, P., d’Abramo, C., Jimenez, H. T., Stauber, M., Friedman, R., & Davies, P. (2013) · Molecular Medicine · doi:10.2119/molmed.2013.00140.revised · Cited by 90
Apolipoprotein E ε4 Is a Determinant for Alzheimer-Type Pathologic Features in Tauopathies, Synucleinopathies, and Frontotemporal Degeneration
Josephs, K. A., Tsuboi, Y., Cookson, N., Watt, H., & Dickson, D. W. (2004) · Archives of Neurology · doi:10.1001/archneur.61.10.1579 · Cited by 70
Self-citation
Sleep disorders in neurodegenerative diseases
Raggi, A., & Ferri, R. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03034.x · Cited by 68
18F-florbetaben Aβ imaging in mild cognitive impairment
Ong, K. T., Villemagne, V. L., Bahar‐Fuchs, A., Lamb, F., Chételat, G., Raniga, P., Mulligan, R. S., Salvado, O., Pütz, B., Roth, K. S., et al. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt158 · Cited by 68
The Role of Cholesterol and Statins in Alzheimer's Disease
Miller, L. J., & Chacko, R. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d104 · Cited by 62
Dementia with Lewy Bodies
Ferman, T. J., & Boeve, B. F. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.001 · Cited by 68
Inhibition of AMPA receptor trafficking at hippocampal synapses by β-amyloid oligomers: the mitochondrial contribution
Rui, Y., Gu, J., Yu, K., Hartzell, H. C., & Zheng, J. Q. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-10 · Cited by 62
Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease
Cabral, G. A., & Griffin-Thomas, L. (2008) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153008785700118 · Cited by 60
A Dominant Role for FE65 (APBB1) in Nuclear Signaling
Yang, Z., Cool, B. H., Martin, G. M., & Hu, Q. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508445200 · Cited by 59
1H NMR Metabolomic Signatures in Five Brain Regions of the AβPPswe Tg2576 Mouse Model of Alzheimer's Disease at Four Ages
Lalande-Martin, J., Halley, H., Balayssac, S., Gilard, V., Dejean, S., Martino, R., Francès, B., Lassalle, J., & Malet‐Martino, M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-130023 · Cited by 60
Identification of non-alkaloid natural compounds of Angelica purpurascens (Avé-Lall.) Gilli. (Apiaceae) with cholinesterase and carbonic anhydrase inhibition potential
Karakaya, S., Bingöl, Z., Koca, M., Dagoglu, S., Pınar, N. M., Demırcı, B., Gülçın, İ., Brestič, M., & Sytar, O. (2019) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2019.11.001 · Cited by 57
Molecular Docking Studies of Coumarins Isolated from Extracts and Essential Oils of Zosima absinthifolia Link as Potential Inhibitors for Alzheimer’s Disease
Karakaya, S., Koca, M., Yılmaz, S. V., Yıldırım, K., Pınar, N. M., Demırcı, B., Brestic, M., & Sytar, O. (2019) · Molecules · doi:10.3390/molecules24040722 · Cited by 57
Progression of neurofibrillary changes and PHF-τ in end-stage Alzheimer’s disease is different from plaque and cortical microglial pathology
Thal, D. R., Arendt, T., Waldmann, G., Holzer, M., Zedlick, D., Rüb, U., & Schober, R. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00090-6 · Cited by 53
In Vivo Brain Imaging of Tangle Burden in Humans
Small, G. W., Agdeppa, E. D., Kepe, V., Satyamurthy, N., Huang, S., & Barrio, J. R. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:19:3:321 · Cited by 52
Calcyclin binding protein and Siah-1 interacting protein in Alzheimer's disease pathology: neuronal localization and possible function
Wasik, U., Schneider, G., Mietelska‐Porowska, A., Mazurkiewicz, M., Fabczak, H., Weis, S., Zabke, C., Harrington, C. R., Filipek, A., & Niewiadomska, G. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.007 · Cited by 51
Revision of the criteria for Alzheimer's disease: A symposium
DeKosky, S. T., Carrillo, M. C., Phelps, C. H., Knopman, D. S., Petersen, R. C., Frank, R., Schenk, D., Masterman, D. M., Siemers, E., Cedarbaum, J. M., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.12.007 · Cited by 52
In vivo amyloid imaging in Alzheimer?s disease
Sair, H. I., Doraiswamy, P. M., & Petrella, J. R. (2004) · Neuroradiology · doi:10.1007/s00234-003-1034-9 · Cited by 50
NPT088 reduces both amyloid‐β and tau pathologies in transgenic mice
Levenson, J. M., Schroeter, S., Carroll, J. C., Cullen, V., Asp, E., Proschitsky, M., Chung, C. H. ‐., Gilead, S., Nadeem, M., Dodiya, H. B., et al. (2016) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2016.06.004 · Cited by 47
Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.
Wang, D., Dickson, D. W., & Malter, J. S. (2008) · PubMed Central · Cited by 47
Self-citation
Activation of Human Macrophages by Amyloid-β Is Attenuated by Astrocytes
Smits, H. A., van Beelen, A. J., Vos, N., Rijsmus, A., van der Bruggen, T., Verhoef, J., Muiswinkel, F. L. V., & Nottet, H. S. L. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6869 · Cited by 46
BZYX, a novel acetylcholinesterase inhibitor, significantly improved chemicals-induced learning and memory impairments on rodents and protected PC12 cells from apoptosis induced by hydrogen peroxide
Zhang, J., Zhu, D., Sheng, R., Wu, H., Hu, Y., Wang, F., Cai, T., Yang, B., & He, Q. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.054 · Cited by 45
Antioxidant and anticholinesterase potential of Ferulago cassia with farther bio-guided isolation of active coumarin constituents
Karakaya, S., Koca, M., Sytar, O., Dursunoglu, B., Özbek, H., Duman, H., Güvenalp, Z., & Kılıç, C. S. (2019) · South African Journal of Botany · doi:10.1016/j.sajb.2019.01.020 · Cited by 44
APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy
Tsuboi, Y., Josephs, K. A., Cookson, N., & Dickson, D. W. (2003) · Neurology · doi:10.1212/01.wnl.0000044340.37138.a9 · Cited by 45
Self-citation
Alzheimer's Disease and Down Syndrome: From Meiosis to Dementia
Petronis, A. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7128 · Cited by 44
Utility of Autoantibodies as Biomarkers for Diagnosis and Staging of Neurodegenerative Diseases
DeMarshall, C. A., Sarkar, A., Nagele, E. P., Goldwaser, E. L., Godsey, G. A., Acharya, N. K., & Nagele, R. G. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.05.005 · Cited by 44
Iodinated tracers for imaging amyloid plaques in the brain
Kung, H. F. (2003) · Molecular Imaging and Biology · doi:10.1016/j.mibio.2003.09.003 · Cited by 39
Repair and regeneration: ferroptosis in the process of remodeling and fibrosis in impaired organs
Yin, J., Xu, X., Guo, Y., Sun, C., Yang, Y., Liu, H., Yu, P., Wu, T. S., & Song, X. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02181-2 · Cited by 42
NMDA receptor antagonists reduce amyloid-β deposition by modulating calpain-1 signaling and autophagy, rescuing cognitive impairment in 5XFAD mice
Companys‐Alemany, J., Turcu, A. L., Schneider, M., Müller, C. E., Vázquez, S., Griñán‐Ferré, C., & Pallàs, M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04438-4 · Cited by 43
Can insulin signaling pathways be targeted to transport Aβ out of the brain?
Vandal, M., Bourassa, P., & Calon, F. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00114 · Cited by 37
Rosiglitazone prevents the memory deficits induced by amyloid-beta oligomers via inhibition of inflammatory responses
Xu, S., Guan, Q., Wang, C., Wei, X., Chen, X., Zheng, B., An, P., Zhang, J., Chang, L. Y., Zhou, W., et al. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.06.010 · Cited by 36
Randomization of Amyloid‐β‐Peptide(1‐42) Conformation by Sulfonated and Sulfated Nanoparticles Reduces Aggregation and Cytotoxicity
Saraiva, A. M., Cardoso, I., Saraiva, M. J., Tauer, K., Pereira, M. D. C., Coelho, M. A. N., Möhwald, H., & Brezesinski, G. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.200900448 · Cited by 36
Antioxidant and anticholinesterase activities of Ferulago syriaca Boiss. and F. isaurica Peșmen growing in Turkey
Karakaya, S., Koca, M., Kılıç, C. S., & Çoşkun, M. (2018) · Medicinal Chemistry Research · doi:10.1007/s00044-018-2196-7 · Cited by 33
Synthesis and preliminary evaluation of 2‐arylhydroxyquinoline derivatives for tau imaging
Tago, T., Furumoto, S., Okamura, N., Harada, R., Ishikawa, Y., Arai, H., Yanai, K., Iwata, R., & Kudo, Y. (2013) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3133 · Cited by 32
Decreased nicotinic receptors and cognitive deficit in rats intracerebroventricularly injected with beta‐amyloid peptide(1‐42) and fed a high‐cholesterol diet
Liu, R., Gu, R., Qi, X., Zhang, T., Zhao, Y. D., He, Y., Pei, J.-J., & Guan, Z. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21463 · Cited by 31
Systematic review of the efficacy of statins for the treatment of Alzheimer’s disease
Mejías-Trueba, M., Pérez-Moreno, M. A., & Fernández-Arche, M. Á. (2018) · Clinical Medicine · doi:10.7861/clinmedicine.18-1-54 · Cited by 31
Effects of statins on α7 nicotinic receptor, cholinesterase and α-form of secreted amyloid precursor peptide in SH-SY5Y cells
ROENSCH, J., Crisby, M., Nordberg, A. K., XIAO, Y., ZHANG, L., & GUAN, Z. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.02.001 · Cited by 31
Candidate PET Radioligand Development for Neurofibrillary Tangles: Two Distinct Radioligand Binding Sites Identified in Postmortem Alzheimer’s Disease Brain
Cai, L., Qu, B., Hurtle, B. T., Dadiboyena, S., Diaz-Arrastia, R. R., & Pike, V. W. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00051 · Cited by 30
Histamine Induces Alzheimer’s Disease-Like Blood Brain Barrier Breach and Local Cellular Responses in Mouse Brain Organotypic Cultures
Sedeyn, J. C., Wu, H., Hobbs, R. D., Levin, E. C., Nagele, R. G., & Venkataraman, V. (2015) · BioMed Research International · doi:10.1155/2015/937148 · Cited by 31
Imaging Brain Metabolism and Pathology in Alzheimer ’s Disease with Positron Emission Tomography
D, R. W. C. (2014) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000143 · Cited by 31
APP transgenic mice: The effect of active and passive immunotherapy in cognitive tasks
Röskam, S., Neff, F., Schwarting, R. K. W., Bacher, M., & Dodel, R. C. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.10.006 · Cited by 29
NetDecoder: a network biology platform that decodes context-specific biological networks and gene activities
da Rocha, E. L., Ung, C. Y., McGehee, C. D., Correia, C., & Li, H. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw166 · Cited by 28
Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer’s Disease and APPswe/PS1dE9 Double Transgenic Mice Brains
Zhang, J., Wang, S., Huang, W. C., Bennett, D. A., Dickson, D. W., Wang, D., & Wang, R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9413-x · Cited by 26
Self-citation
Dioscin Protects against Aβ1–42 Oligomers-Induced Neurotoxicity via the Function of SIRT3 and Autophagy
Zhang, Z., Han, K., Wang, C., Sun, C., & Jia, N. (2020) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c20-00046 · Cited by 24
Lovastatin stimulates up-regulation of α7 nicotinic receptors in cultured neurons without cholesterol dependency, a mechanism involving production of the α-form of secreted amyloid precursor protein
Xiu, J., Nordberg, A. K., Shan, K.-R., Yu, W., Olsson, J. M., Nordman, T., Mousavi, M. T., & Guan, Z. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20658 · Cited by 24
Copper–amyloid-β complex may catalyze peroxynitrite production in brain: evidence from molecular modeling
Giacovazzi, R., Ciofini, I., Rao, L., Amatore, C. A., & Adamo, C. (2014) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp54839b · Cited by 23
Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-β1-42 and Key Cell Surface Proteins During Alzheimer’s Disease Pathogenesis
Goldwaser, E. L., Acharya, N. K., Wu, H., Godsey, G. A., Sarkar, A., DeMarshall, C. A., Kosciuk, M. C., & Nagele, R. G. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190962 · Cited by 22
Chemical imaging delineates Aβ plaque polymorphism across the Alzheimer’s disease spectrum
Koutarapu, S., Ge, J., Dulewicz, M., Srikrishna, M., Szadziewska, A., Wood, J. I., Blennow, K., Zetterberg, H., Michno, W., Ryan, N. S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59085-7 · Cited by 29
Increased amyloid β-peptide uptake in skeletal muscle is induced by hyposialylation and may account for apoptosis in GNE myopathy
Bosch-Morató, M., Iriondo, C., Guivernau, B., Valls-Comamala, V., Vidal, N., Olivé, M., Querfurth, H. W., & Muñoz, F. J. (2016) · Oncotarget · doi:10.18632/oncotarget.7997 · Cited by 21
Immunological Aspects of Alzheimer??s Disease
Hoozemans, J. J. M., Rozemüller, A. J. M., Veerhuis, R., & Eikelenboom, P. (2001) · BioDrugs · doi:10.2165/00063030-200115050-00004 · Cited by 21
CD45RB Is a Novel Molecular Therapeutic Target to Inhibit Aβ Peptide-Induced Microglial MAPK Activation
Zhu, Y., Hou, H., Nikolic, W. V., Ehrhart, J. C., Rrapo, E., Bickford, P. C., Giunta, B. N., & Tan, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002135 · Cited by 21
Isotope-edited FTIR reveals distinct aggregation and structural behaviors of unmodified and pyroglutamylated amyloid β peptides
Goldblatt, G., Matos, J. O., Gornto, J., & Tatulian, S. A. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp03343h · Cited by 20
Intracellular pathways involved in TNF-α and superoxide anion release by Aβ(1–42)-stimulated primary human macrophages
Smits, H. A., Vos, N., Wat, J. W. Y., van der Bruggen, T., Verhoef, J., & Nottet, H. S. L. M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00254-5 · Cited by 23
Modulating Metals As A Therapeutic Strategy For Alzheimer’s Disease
Hung, L. W., & Barnham, K. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.32 · Cited by 18
Structure and permeability changes of the blood-brain barrier in APP/PS1 mice: an Alzheimer’s disease animal model
Wang, Y., Liu, J., Zhang, Z., Wang, X., & Zhang, C. (2011) · Neurochemical Journal · doi:10.1134/s1819712411030135 · Cited by 16
Chiral supramolecular coordination cages as high-performance inhibitors against amyloid-β aggregation
Bao, L., Hao, S., Xi, S., Yan, X., Zhang, H., Shen, R., & Gu, Z. (2018) · Chemical Communications · doi:10.1039/c8cc04913k · Cited by 16
Chemical Composition, Antioxidant and Anticholinesterase Activities of the Essential oil of Origanum rotundifolium Boiss. from Turkey
Özbek, H., Güvenalp, Z., Özek, T., Sevindik, H. G., Yuca, H., Yerdelen, K. Ö., & Demirezer, L. Ö. (2017) · Records of Natural Products · doi:10.25135/rnp.62.16.05.040 · Cited by 15
Antioxidant, Antimicrobial and Anticholinesterase Activities of Ferulago pauciradiata Boiss. & Heldr. Growing in Turkey
Karakaya, S., Koca, M., Şimşek, D., DELİMUSTAFAOĞLU, F. G., Özbek, H., Kılıç, C. S., Güvenalp, Z., Demırcı, B., & Altanlar, N. (2018) · Journal of Biologically Active Products from Nature · doi:10.1080/22311866.2018.1503562 · Cited by 15

Authors: Dickson, D. W.
Affiliations: Albert Einstein College of Medicine (US)
Corresponding author: Dickson, D.W
ORCID: Dickson, D.W
Venue: Neurobiology of Aging
Publisher: Elsevier BV
Published: 1997-07
Volume: 18
Issue: 4
Pages: S21-S26
ISSN: 0197-4580 (ISSN-L)
DOI: 10.1016/s0197-4580(97)00065-1
OpenAlex: W2011769584
Cited by: 168
References: 44
Citations by year: 2026: 4 · 2025: 2 · 2024: 4 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 11 · 2018: 15 · 2017: 7 · 2016: 8 · 2015: 7 · 2014: 11 · 2013: 12 · 2012: 12
FWCI: 1.02
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neurobiology of Aging (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p01ag006803-11)
U.S. Public Health Service (NIA 03949)
National Institute on Aging (AG-06803)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, neuropathological diagnosis, amyloid plaques, neurofibrillary degeneration, paired helical filaments, neuritic plaques, amyloid deposits, neuropil threads, dementia, clinicopathological correlation, diagnostic criteria
MeSH terms: Adult, Aged, Aged, 80 and over, Aging, Alzheimer Disease, Brain, Cell Count, Diagnosis, Differential, Humans, Longitudinal Studies, Middle Aged, Parkinson Disease, Prospective Studies, Severity of Illness Index, Neurofibrillary Tangles, Neuropil Threads, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks